Immunosuppressive Agents: all 5,940 studies that test it
Page 37 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- Azathioprine Based on Endoscopy After Clinical Remission in Moderate to Severe Ulcerative ColitisTerminatedNCT02579733Phase 4
- Study Assessing Cognition in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Treated With BG00012CompletedNCT02579681Phase 3
- Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS TumorsActive, not recruitingNCT02574728Phase 2
- Open Label Study of Everolimus (RAD001) in Patients With Segmental Overgrowth SyndromeWithdrawnNCT02569125Phase 2
- Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic MalignanciesCompletedNCT02566395Phase 3
- Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMDWithdrawnNCT02563782Phase 2
- Adjuvant Chemotherapy of Three-step Regimen in Ovarian CancerStatus unknownNCT02562365Phase 2
- A Study of Daclizumab (Zenapax) in Combination With Mycophenolate Mofetil (CellCept) and Sirolimus in Prevention of Acute Rejection in Heart Transplant ParticipantsCompletedNCT02554955Phase 4
- Comparison of Compliance and Evolution of Functional Capacity of Patients With Rheumatoid Arthritis Treated by Methotrexate Either by Auto-injector or by Conventional Sub-cutaneous SyringeCompletedNCT02553018Phase 3
- Reduced Intensity Conditioning Before Partially Matched Donor Stem Cell Transplant in Treating Patients With Advanced Cutaneous T Cell LymphomaWithdrawnNCT02548468Phase 1
- Study on Therapy With Dimethylfumarate (DMF) in Patients With Cutaneous T Cell Lymphoma (CTCL)CompletedNCT02546440Phase 2
- Once-a-day Tacrolimus Conversion Study: The OneTAC TrialStatus unknownNCT02545972Phase 4
- Prospective Donor Specific T Response Measurment for IS Minimization in de Novo Renal TransplantationCompletedNCT02540395Not applicable
- Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaWithdrawnNCT02538926Phase 2
- The Research of Standard Diagnosis and Treatment for HSPN in ChildrenStatus unknownNCT02532777Phase 2
- Comparison of Single-Agent Carboplatin vs the Combination of Carboplatin and Everolimus for the Treatment of Advanced Triple-Negative Breast CancerCompletedNCT02531932Phase 2
- Bioequivalence Evaluation of a New and Current Tablet of ASP015KCompletedNCT02531191Phase 1
- Safety and Efficacy of an Immunoablative Nonmyeloablative Conditioning Protocol for Autologous Bone Marrow Transplantation (BMT) in Patients With Multiple Sclerosis (MS)Status unknownNCT02529839Not applicable
- CD19-Specific T-cells in Treating Patients With Advanced Lymphoid MalignanciesCompletedNCT02529813Phase 1
- Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With MyelofibrosisWithdrawnNCT02528877Phase 1
- Immune Modulation Therapy for Pompe DiseaseStatus unknownNCT02525172Phase 4
- Sirolimus for the Treatment of HyperinsulinismWithdrawnNCT02524639Phase 1/2
- Study of Isatuximab Combined With Bortezomib + Cyclophosphamide + Dexamethasone (VCD) and Bortezomib + Lenalidomide + Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma (MM) Non Eligible for Transplant or No Intent for Immediate TransplantationCompletedNCT02513186Phase 1
- Carfilzomib in Combination With Cyclophosphamide and Etoposide for ChildrenCompletedNCT02512926Phase 1
- Maintenance Aromatase Inhibitors (AIs)+ Everolimus vs AIs in Hormone Receptor Positive Metastatic Breast Cancer PatientsCompletedNCT02511639Phase 3
- suPERficial Slow-flow Vascular malFORMations Treated With sirolimUSCompletedNCT02509468Phase 2
- Minimal Islet Transplant at Diabetes OnsetCompletedNCT02505893Phase 2
- Thalidomide in Treating Crohn's DiseaseCompletedNCT02501291Phase 2
- Belimumab Impacting Transplant EligibilityCompletedNCT02500251Phase 1/2
- Pharmacokinetic Study of ENVARSUS in Adult De-novo Kidney Transplant PatientsCompletedNCT02500212Phase 4
- Nivolumab After Induction Treatment in Triple-negative Breast Cancer (TNBC) PatientsActive, not recruitingNCT02499367Phase 2
- Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid TumorsActive, not recruitingNCT02498912Phase 1
- Traumatic Brain Injury and Effects of Acute Cyclosporine AWithdrawnNCT02496975Phase 1/2
- The Effects of Conversion From Cyclosporine to Tacrolimus on the Changes of Cardiovascular Risk Profiles and Serum Metabolites in Renal Transplant RecipientsStatus unknownNCT02496494Phase 4
- Effects of Everolimus in Left Ventricular Hypertrophy After Conversion From Azathioprine: A Pilot StudyStatus unknownNCT02493465Phase 4
- A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade GliomaCompletedNCT02490930Early Phase 1
- Etanercept Versus Adalimumab in the Treatment of Patients With Ankylosing Spondylitis. A Switch StudyStatus unknownNCT02489760Phase 4
- In Vivo Persistence of Adoptively-Transferred TIL Cultured With Akti in People With Metastatic MelanomaWithdrawnNCT02489266Phase 1
- Allo-HSCT With Alternative Donor in Treatment of Hematologic MalignancyCompletedNCT02487069Not applicable
- Food Effect and Bioavailability of Deflazacort Formulations in Healthy VolunteersCompletedNCT02485431Phase 1
- Rapamycine vs Placebo for the Treatment of Inclusion Body MyositisCompletedNCT02481453Phase 2/3
- PRednisone Plus EVerolimus in Patients With Metastatic Renal Cell Cancer After Failure of VEGFR -TKITerminatedNCT02479490Phase 2
- Proof-of-concept Study of Forward Pharma (FP)187 in Patients With Mild/Moderate Psoriatic ArthritisWithdrawnNCT02475304Phase 2
- Study to Explore the Onset of Efficacy on Magnetic Resonance Disease Activity of BG00012 (Dimethyl Fumarate) in Patients With Relapsing remitTing Multiple SclerosisWithdrawnNCT02472938Phase 4
- Study To Examine Toxicity Of Allogeneic Stem Cell Transplantation For Relapsed Or Therapy Refractory Ewings SarcomaCompletedNCT02472392Phase 1
- Tecfidera and the Gut MicrobiotaCompletedNCT02471560Phase 4
- Relapse Myeloma; Cyclofosfamide; Bortezomib; MaintenanceCompletedNCT02467010Phase 2
- Efficacy of Tacrolimus in Adults With Facial Non-segmental Vitiligo - VITACCompletedNCT02466997Phase 3
- Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease ActivityStatus unknownNCT02466581Phase 4
- Pilot Study of Autologous T-cells in Patients With Metastatic Pancreatic CancerTerminatedNCT02465983Phase 1
- Investigation of the Effect of Dimethyl Fumarate on T Cells in Patients With Relapsing Remitting Multiple SclerosisCompletedNCT02461069Phase 4
- Cyclophosphamide for Acute Exacerbation of Idiopathic Pulmonary FibrosisCompletedNCT02460588Phase 3
- Methotrexate Infusion Into Fourth Ventricle in Children With Recurrent Malignant Fourth Ventricular Brain TumorsCompletedNCT02458339Phase 1
- A Study to Compare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus NephritisCompletedNCT02457221Phase 3
- Study to Investigate the Effect of BMS-986142 on the Pharmacokinetics (PK) of Methotrexate and Probe Substrate Cocktail in Healthy PatientsCompletedNCT02456844Phase 1
- Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell MalignanciesStatus unknownNCT02456350Phase 1
- Topical Tacrolimus in Vernal KeratoconjunctivitisStatus unknownNCT02456025Phase 4
- Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the PancreasActive, not recruitingNCT02451982Phase 2
- Adjuvant FEC Versus EP in Breast Cancer (MIG5)CompletedNCT02450058Phase 3
- The Pilot Study Evaluate the Safety and Efficacy of Sirolimus in Patients With PIK3CA Mutation and/or PIK3CA Amplification Refractory Solid TumorsCompletedNCT02449564Not applicable
- Study to Evaluate the Safety and Efficacy of Everolimus, in Subjects With PIK3CA Amplification, PTEN Loss and PIK3CA Mutation Refractory Solid TumorsCompletedNCT02449538Phase 2
- Thymoglobulin Induction Therapy in Kidney Transplantation (6mg/kg vs 4mg/kg)Status unknownNCT02447822Phase 4
- Allogeneic Stem Cell Transplantation for Patients With Multiple MyelomaWithdrawnNCT02447055Early Phase 1
- Total Marrow and Lymphoid Irradiation and Chemotherapy Before Donor Transplant in Treating Patients With Myelodysplastic Syndrome or Acute LeukemiaCompletedNCT02446964Phase 1
- Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCLStatus unknownNCT02445404Phase 2
- Cyclophosphamide and Hydroxychloroquine for Thrombocytopenia in SLETerminatedNCT02444728Phase 3
- Cyclophosphamide in Myalgic Encephalopathy/ Chronic Fatigue Syndrome (ME/CFS)CompletedNCT02444091Phase 2
- Sirolimus Effect on Hypertrophic Syndromes Related Gene PIK3CACompletedNCT02443818Phase 2
- Clinical and Immunohistochemical Effect of Topical Pimecrolimus in Treatment of Oral Lichen PlanusCompletedNCT02443311Phase 4
- Treatment of Rapid Onset Obesity, Hypoventilation, Hypothalamic Dysfunction, and Autonomic Dysregulation (ROHHAD )WithdrawnNCT02441491Not applicable
- Evaluation of the Immunological Effects of a Combined Treatment With Radiation and Cyclophosphamide in Metastasized Breast Cancer PatientsWithdrawnNCT02441270Early Phase 1
- 3RD GENERATION GD2 SPECIFIC CHIMERIC ANTIGEN RECEPTOR TRANSDUCED AUTOLOGOUS NATURAL KILLER T-CELLS FOR NEUROBLASTOMAWithdrawnNCT02439788Phase 1
- Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell LymphomaActive, not recruitingNCT02436707Phase 2
- Very Early Versus Delayed Etanercept in Patients With RACompletedNCT02433184Phase 4
- Multicentre, Open Label, Randomized, Two-arm, Parallel-group Study to Assess Efficacy and Safety of ENVARSUS® Compared With Tacrolimus Used as Per Current Clinical Practice in the Initial Maintenance Setting in de Novo Kidney Transplant PatientsCompletedNCT02432833Phase 4
- A Study to Demonstrate Safety and Efficacy of Advagraf in Patients Undergoing Kidney or Liver Transplantation in IndiaCompletedNCT02432053Phase 4
- Trial With Gemcitabine and Rapamycin in Second Line of Metastatic OsteosarcomaCompletedNCT02429973Phase 2
- Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS)WithdrawnNCT02428218Phase 3
- Phase I Clinical Trial of Cryoimmunotherapy Against Prostate CancerCompletedNCT02423928Phase 1
- Mature Dendritic Cell Vaccination Against Unique Immunogenic Peptides in Patients With Non Small Cell Lung Cancer (NSCLC)WithdrawnNCT02419170Early Phase 1
- TILs & Low-Dose IL-2 Therapy Following Cyclophosphamide and Fludarabine in Pleural Mesothelioma PatientsCompletedNCT02414945Phase 1/2
- Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen MesothelinActive, not recruitingNCT02414269Phase 1/2
- Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic RemissionStatus unknownNCT02412085Phase 4
- Ixazomib in Combination With Thalidomide - Dexamethasone in Patients With Relapsed and/or Refractory Multiple MyelomaCompletedNCT02410694Phase 2
- BNHL-2015 for Children or Adolescents in ChinaActive, not recruitingNCT02405676Phase 2/3
- Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast CancerStatus unknownNCT02404051Phase 3
- Celiac Plexus Block for Chronic Pancreatitis RCTTerminatedNCT02399800Not applicable
- Ciclosporin to Protect Renal Function In Cardiac SurgeryCompletedNCT02397213Phase 2
- Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial CancerActive, not recruitingNCT02397083Phase 2
- Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS TumorsCompletedNCT02390843Phase 1
- Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing Human Thyroglobulin to People With Thyroglobulin Expressing Thyroid CancerWithdrawnNCT02390739Phase 1/2
- Ciclosporin to Reduce Reperfusion Injury in Primary PCICompletedNCT02390674Phase 2
- Vaccination in Prostate Cancer (VANCE)CompletedNCT02390063Phase 1
- Methotrexate and Cytosine in Adult Langerhans Cell HistiocytosisCompletedNCT02389400Phase 2
- Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid TumorsActive, not recruitingNCT02389309Phase 1
- Human Clinical Trial of Uterine Transplantation in the United KingdomStatus unknownNCT02388802Not applicable
- Gefitinib Combined With Thalidomide to Treat NSCLCStatus unknownNCT02387086Phase 2/3
- Etiologic Treatment With Benznidazole in Adult Patients With Chronic Chagas Disease. A Randomized Clinical TrialCompletedNCT02386358Phase 3
- HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIACompletedNCT02379520Phase 1
- TTT Versus TTT and Triamcinolone to Decrease Exudation in Choroidal Melanoma After Proton Beam TherapyStatus unknownNCT02379000Phase 4